Why Semaglutide Is Changing Medical Weight Loss on the Gulf Coast

Written by Kristy Beard, MSN, APRN, FNP-C — Board-Certified Family Nurse Practitioner and Founder of Elevate Health and Wellness, serving patients across the Gulf Coast in Gautier, MS and Foley, AL. | Clinically reviewed: July 13, 2026

The Weight Loss Conversation Has Changed

If you've been struggling with your weight for years — trying diet after diet, working with personal trainers, cutting carbs, counting calories — and still not seeing the results you deserve, I want you to know something important: it may not be a willpower problem. It may be a biology problem.

Over the past several years, a medication called semaglutide has fundamentally changed what's possible in medical weight loss. As a board-certified Family Nurse Practitioner, I've seen this medication help patients on the Gulf Coast lose weight in ways that diet and exercise alone simply couldn't achieve — and the science behind it is compelling.

What Is Semaglutide?

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist — a class of medication originally developed to treat type 2 diabetes. GLP-1 is a hormone your body naturally produces in your gut after eating. It signals your brain that you're full, slows how quickly your stomach empties, and helps regulate blood sugar levels.

When semaglutide is introduced at higher doses specifically for weight management, it amplifies these signals dramatically — reducing appetite, decreasing food cravings, and helping patients feel satisfied with significantly less food. According to a landmark clinical trial published in the New England Journal of Medicine (Wilding et al., 2021), adults with obesity who took semaglutide lost an average of 14.9% of their body weight over 68 weeks — compared to just 2.4% in the placebo group. That's a difference that matters.

Why Gulf Coast Patients Are Turning to Semaglutide

Mississippi and Alabama consistently rank among the states with the highest rates of obesity and obesity-related conditions, including type 2 diabetes, hypertension, and heart disease. According to the Centers for Disease Control and Prevention (CDC), more than 36% of Mississippi adults are classified as obese — one of the highest rates in the nation.

For many of my patients in Gautier and Foley, that means years of being told to "just eat less and move more" — advice that ignores the very real hormonal, metabolic, and neurological factors that drive weight gain. Semaglutide addresses those factors directly. It works with your biology, not against it.

What to Expect When You Start Semaglutide at Elevate

At Elevate Health and Wellness, we don't just hand you a prescription and send you on your way. Every patient who starts a medical weight loss program with us goes through a thorough clinical evaluation first — including comprehensive lab work to assess your thyroid, hormone levels, blood sugar, kidney function, and cardiovascular risk factors. This matters because semaglutide is not appropriate for everyone, and knowing your baseline helps us monitor your progress safely.

We start at a low dose and titrate gradually — typically beginning at 0.25mg weekly and increasing slowly over several weeks based on how your body responds. This approach minimizes the most common side effects, which include nausea, constipation, and mild fatigue, and it gives your body time to adjust.

Most patients begin noticing reduced appetite within the first one to two weeks. Meaningful weight loss typically becomes visible between weeks four and eight. By three months, many of our patients have lost 10 to 20 pounds — and by six months, some are seeing 30 to 50 pounds of weight loss when combined with nutritional guidance and lifestyle support.

Semaglutide vs. Tirzepatide: Which Is Right for You?

You may have heard about tirzepatide (brand name Mounjaro or Zepbound) — another GLP-1 medication that also targets the GIP hormone pathway. Clinical trials published in the New England Journal of Medicine (Jastreboff et al., 2022) showed tirzepatide produced even greater weight loss than semaglutide in head-to-head comparisons, with some patients losing up to 22.5% of their body weight.

At Elevate, we offer both. Which one is right for you depends on your health history, your goals, your budget, and how your body responds to initial treatment. We'll walk through all of that together at your consultation.

Is Medical Weight Loss Covered by Insurance?

This is one of the most common questions I get. The short answer: it depends. Elevate Health and Wellness accepts most major insurance plans and Medicaid in Mississippi. Coverage for GLP-1 medications varies by plan — some cover them fully, others require prior authorization, and some do not cover them at all. We help our patients navigate that process and also offer cash-pay options for patients whose insurance doesn't cover the medication.

A Note on Telehealth Weight Loss Programs

You've probably seen advertisements for telehealth-only weight loss programs that ship semaglutide to your door with minimal evaluation. While access to medication is important, I want to be direct with you as your provider: medical weight loss without proper lab monitoring, clinical oversight, and individualized titration carries real risks. At Elevate, every patient is seen in person or through a thorough telehealth evaluation, and we monitor your labs regularly throughout your program. That's what safe, sustainable weight loss looks like.

Ready to Find Out If Semaglutide Is Right for You?

If you've been curious about semaglutide or medical weight loss and you're ready to have a real conversation with a provider who will actually listen, I'd love to meet you. We serve patients at our Gautier, MS clinic and our Foley, AL location, and telehealth consultations are available across Mississippi and Alabama.

📞 Call or text us at 844-641-6401 or visit our Medical Weight Loss page to learn more and schedule your consultation.

Sources: Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384:989-1002. | Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387:205-216. | Centers for Disease Control and Prevention. Adult Obesity Prevalence Maps. 2023. cdc.gov/obesity.

This article is written by Kristy Beard, MSN, APRN, FNP-C, board-certified Family Nurse Practitioner and founder of Elevate Health and Wellness. Information provided is for educational purposes only and does not constitute medical advice. Please consult a licensed healthcare provider before starting any weight loss medication.